Compare SVRE & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SVRE | TNON |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.8M |
| IPO Year | 2021 | 2021 |
| Metric | SVRE | TNON |
|---|---|---|
| Price | $0.82 | $1.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.50 |
| AVG Volume (30 Days) | 92.3K | ★ 117.6K |
| Earning Date | 08-14-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.90 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,944,000.00 |
| Revenue This Year | $1,756.92 | $52.65 |
| Revenue Next Year | N/A | $47.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.35 |
| 52 Week Low | $0.55 | $1.84 |
| 52 Week High | $6.30 | $45.50 |
| Indicator | SVRE | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 38.99 | 29.78 |
| Support Level | $0.62 | N/A |
| Resistance Level | $3.17 | $4.18 |
| Average True Range (ATR) | 0.18 | 0.17 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 22.40 | 8.82 |
Saverone 2014 Ltd is engaged in the design, development, and commercialization of transportation and safety solutions, designed to prevent car accidents based on its patented technology of detecting, analyzing, and locating cellular phone radio frequency, or RF signals. The company is developing two product lines: the first is an In-Cabin Driver Distraction Prevention Solution (known as SaverOne system), or DDPS; and the second is an Advanced Driver-Assistance System, or ADAS, product that detects vulnerable road users, or VRUs, and provides a warning to the vehicle regarding potential collision. Geographically, Saverone generates maximum revenue from Europe and the rest from Israel.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.